These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 19014094)
21. Preparation and immunoprotection of subgroup B avian leukosis virus inactivated vaccine. Li X; Dong X; Sun X; Li W; Zhao P; Cui Z; Wang X Vaccine; 2013 Nov; 31(46):5479-85. PubMed ID: 24016813 [TBL] [Abstract][Full Text] [Related]
22. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge. Liljebjelke KA; King DJ; Kapczynski DR Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455 [TBL] [Abstract][Full Text] [Related]
23. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine. Nagy E; Krell PJ; Dulac GC; Derbyshire JB Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580 [TBL] [Abstract][Full Text] [Related]
24. Use of enzyme linked immunosorbent assay for estimation of antibody to Newcastle disease virus. Srinivasan VA; Reddy GS; Kalanidhi AP Microbiologica; 1992 Jul; 15(3):319-21. PubMed ID: 1501590 [TBL] [Abstract][Full Text] [Related]
25. Vaccination response of parentally immune chicks after yolk-sac inoculation of the embryo with inactivated Newcastle Disease Virus. Higgins DA Avian Dis; 1971; 15(1):98-101. PubMed ID: 5102180 [No Abstract] [Full Text] [Related]
26. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels. Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638 [TBL] [Abstract][Full Text] [Related]
27. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease. Shen H; Xue C; Lv L; Wang W; Liu Q; Liu K; Chen X; Zheng J; Li X; Cao Y Virus Res; 2013 Dec; 178(2):430-6. PubMed ID: 24050994 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of viable and inactivated Newcastle disease virus vaccines in turkeys. Kelleher CJ; Halvorson DA; Newman JA Avian Dis; 1988; 32(2):342-6. PubMed ID: 3401177 [TBL] [Abstract][Full Text] [Related]
29. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus. Bolte AL; Voss M; Vielitz E; Kaleta EF Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):155-9. PubMed ID: 11370475 [TBL] [Abstract][Full Text] [Related]
31. Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers. Palya V; Tatár-Kis T; Mató T; Felföldi B; Kovács E; Gardin Y Vet Immunol Immunopathol; 2014 Mar; 158(1-2):105-15. PubMed ID: 24368086 [TBL] [Abstract][Full Text] [Related]
32. [Newcastle disease: an enzyme-linked immunosorbent assay for the control of antibodies in chicks]. Oppliger A Schweiz Arch Tierheilkd; 1991; 133(8):391-4. PubMed ID: 1962182 [TBL] [Abstract][Full Text] [Related]
34. [The transmission of maternal Newcastle disease antibodies in pheasants]. Müller H Berl Munch Tierarztl Wochenschr; 1993 Sep; 106(9):305-6. PubMed ID: 8216198 [TBL] [Abstract][Full Text] [Related]
35. [Vaccination of ostriches (Struthio camelus, Linnaeus, 1758) against Newcastle disease: evidence for vaccine compatibility and seroconversion after vaccinations using the hemagglutination inhibition and virus neutralization tests]. Bolte AL; Voelckel K; Kaleta EF Dtsch Tierarztl Wochenschr; 1999 Feb; 106(2):62-5. PubMed ID: 10085579 [TBL] [Abstract][Full Text] [Related]
36. Immune responses of poultry to Newcastle disease virus. Kapczynski DR; Afonso CL; Miller PJ Dev Comp Immunol; 2013 Nov; 41(3):447-53. PubMed ID: 23623955 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the cell-mediated immune response of chickens vaccinated with Newcastle disease virus as determined by the under-agarose leukocyte-migration-inhibition technique. Agrawal PK; Reynolds DL Avian Dis; 1991; 35(2):360-4. PubMed ID: 1830203 [TBL] [Abstract][Full Text] [Related]
38. A model for the transfer of passive immunity against Newcastle disease and avian influenza in specific pathogen free chickens. Lardinois A; van den Berg T; Lambrecht B; Steensels M Avian Pathol; 2014; 43(2):118-24. PubMed ID: 24397892 [TBL] [Abstract][Full Text] [Related]
39. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183 [TBL] [Abstract][Full Text] [Related]
40. Further studies on the adjuvant effect of an interferon inducer (BRL 5907) on Newcastle disease and avian influenza inactivated vaccines. Gough RE; Allan WH; Knight DJ; Lieper JW Res Vet Sci; 1975 Sep; 19(2):185-8. PubMed ID: 1172622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]